1. Home
  2. VOYA vs CYTK Comparison

VOYA vs CYTK Comparison

Compare VOYA & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOYA
  • CYTK
  • Stock Information
  • Founded
  • VOYA 1975
  • CYTK 1997
  • Country
  • VOYA United States
  • CYTK United States
  • Employees
  • VOYA N/A
  • CYTK N/A
  • Industry
  • VOYA Life Insurance
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • VOYA Finance
  • CYTK Health Care
  • Exchange
  • VOYA Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • VOYA 6.8B
  • CYTK 5.6B
  • IPO Year
  • VOYA 2013
  • CYTK 2004
  • Fundamental
  • Price
  • VOYA $67.02
  • CYTK $31.70
  • Analyst Decision
  • VOYA Buy
  • CYTK Buy
  • Analyst Count
  • VOYA 13
  • CYTK 19
  • Target Price
  • VOYA $80.42
  • CYTK $77.33
  • AVG Volume (30 Days)
  • VOYA 996.8K
  • CYTK 2.3M
  • Earning Date
  • VOYA 05-06-2025
  • CYTK 05-06-2025
  • Dividend Yield
  • VOYA 2.69%
  • CYTK N/A
  • EPS Growth
  • VOYA N/A
  • CYTK N/A
  • EPS
  • VOYA 5.31
  • CYTK N/A
  • Revenue
  • VOYA $7,968,000,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • VOYA N/A
  • CYTK $55.84
  • Revenue Next Year
  • VOYA $5.08
  • CYTK $646.96
  • P/E Ratio
  • VOYA $12.57
  • CYTK N/A
  • Revenue Growth
  • VOYA 5.34
  • CYTK 412.21
  • 52 Week Low
  • VOYA $52.43
  • CYTK $31.67
  • 52 Week High
  • VOYA $84.30
  • CYTK $68.44
  • Technical
  • Relative Strength Index (RSI)
  • VOYA 64.92
  • CYTK 29.83
  • Support Level
  • VOYA $59.90
  • CYTK $31.67
  • Resistance Level
  • VOYA $67.56
  • CYTK $43.51
  • Average True Range (ATR)
  • VOYA 1.70
  • CYTK 1.97
  • MACD
  • VOYA 1.36
  • CYTK -0.78
  • Stochastic Oscillator
  • VOYA 94.40
  • CYTK 0.21

About VOYA Voya Financial Inc.

Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: